Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe.

Next Previous
Trial Profile

Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bazedoxifene (Primary) ; Bisphosphonates; Raloxifene
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions
  • Sponsors Pfizer

Most Recent Events

  • 03 Jun 2019 Status changed from active, no longer recruiting to completed.
  • 14 Mar 2018 Planned End Date changed from 30 Apr 2019 to 1 Apr 2019.
  • 14 Mar 2018 Planned primary completion date changed from 30 Apr 2019 to 1 Apr 2019.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top